Anaplastic transformation of a papillary carcinoma of the thyroid in a patient with Graves' disease with varied activity of thyrotropin receptor antibodies

Thyroid

Volumn 8, Issue 1, 1998, Pages 53-58

  Fujikawa, Megumi ^a   Okamura, Ken ^a   Sato, Kaori ^a   Asano, Tamotsu ^a   Yamasaki, Koji ^a   Hirata, Tsuneo ^a   Ohta, Masayuki ^a   Mizokami, Tetsuya ^a   Kuroda, Takeo ^a   Fujishima, Masatoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IODINE 123; LIOTHYRONINE; THIAMAZOLE; THYROGLOBULIN; THYROID ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE; VIMENTIN;

AGED; ANAPLASTIC CARCINOMA; ARTICLE; ASPIRATION CYTOLOGY; CASE REPORT; ECHOGRAPHY; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MALE; PAPILLARY CARCINOMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THORAX RADIOGRAPHY; THYROID CARCINOMA; THYROID FUNCTION TEST; THYROID SCINTISCANNING; TUMOR VOLUME;

EID: 13144256788     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.53     Document Type: Article

References (22)

1. Duh QY, Grossman RF 1995 Thyroid growth factors, signal transduction pathways, and oncogenes. Surg Clin North Am 75:421-437.
2. Clark O 1981 TSH suppression in the management of thyroid nodules and thyroid cancer. World J Surg 5:39-47.
3. Ozaki O, Ito K, Kobayashi K, Toshima K, Iwasaki H, Yashiro T 1990 Thyroid carcinoma in Graves' disease. World J Surg 14:437-441.
4. Belfiore A, Garofalo MR, Giuffrida D, Runello F, Filetti S, Fiumara A, Ippolito O, Vigneri R 1990 Increased aggressiveness of thyroid cancer in patients with Graves' disease. J Clin Endocrinol Metab 70:830-835.
5. Kasuga Y, Sugenoya A, Kobayashi S, Masuda H, lida F 1993 The outcome of patients with thyroid carcinoma and Graves' disease. Jpn J Surg 23:9-12.
6. Hales IB, McElduff A, Crummer P, Clifton-Bligh P, Delbridge L, Hoschl R, Poole A, Reeve ST, Wilmshurst E, Wiseman J 1992 Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer. J Clin Endocrinol Metab 75:886-889.
7. Fletti S, Belfiore A, Amir SM, Daniels GH, Ippolito O, Vigneri R, Ingbar SH 1988 The role of thyroid-stimulating antibodies of Graves' disease in differetiated thyroid cancer. N Engl J Med 318:753-759.
8. Hori Y, Kashima K, Daa T, Yokoyama S, Nakayama I, Noguchi S 1995 Relationship between cell proliferation activity and morphological characteristics of papillary microcarcinoma in the thyroid of Graves' disease. Pathol Int 45:846-853.
9. Venkatesh YSS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H, Samaan NA 1990 Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 66:321-330.
10. Demeter JG, De Jong SA, Lawrence AM, Paloyan E 1991 Anaplastic thyroid carcinoma: Risk factors and outcome. Surgery 110:956-961.
11. Getaz EP, Shimaoka K, Rao U 1979 Anaplastic carcinoma of the thyroid following external irradiation. Cancer 43:2248-2253.
12. Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang S-H, Koeffler HP 1993 High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 91:179-84.
13. Rees Smith B, McLachlan SM, Furmianak J 1988 Autoantibodies to the thyrotropin receptor. Endocr Rev 9:106-121.
14. Cho BY, Shong YK, Lee HK, Koh CS, Min HK 1989 Graves' hyperthyroidism following primary hypothyroidism: Sequential changes in various activities of thyrotropin receptor antibodies. Acta Endocrinol 120:447-450.
15. Kraiem Z, Baron E, Kahana L, Sadeh O, Sheinfeld M 1992 Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper-thyroidism and back to hypothyroidism. Clin Endocrinol (Oxf) 36:211-216.
16. Cooper DS 1996 Treatment of thyrotoxicosis. In: Braverman LE, Utiger RD (eds) The Thyroid. 7th ed. JB Lippinocott, New York, pp. 713-728.
17. Shiroozu A, Okamura K, Ikenoue H, Sato K, Nakashima T, Yoshinari T, Fujishima M 1986 Treatment of hyperthyroidism with a small single daily dose of methimazole. J Clin Endocrinol Metab 63:125-128.
18. Vinette DS, MacDonald LL, Yazdi HM 1991 Papillary carcinoma of the thyroid with anaplastic transformation: Diagnostic pitfalls in fine-needle aspiration biopsy. Diag Cytopathol 7:75-78.
19. Tanaka N, Kobayashi T, Higaki N, Miyauchi K, Shiba E, Mori T, Mashita K, Fujita N, Takaki S 1993 Analysis of growth curves of pulmonary metastases in patients with anaplastic thyroid cancer [in Japanese] J Jpn Prac Surg Soc 54:559-563.
20. Mizukami Y, Hashimoto T, Nonomura A, Michigishi T, Nakamura S, Noguchi M, Matsukawa S 1994 Immunohistochemical demonstration of thyrotropin (TSH)-receptor in normal and diseased human thyroid tissues using monoclonal antibody against recombinant human TSH-receptor protein. J Clin Endocrinol Metab 79:616-619.
21. Brönnegård M, Törring O, Böös J, Sylven C, Marcus C, Wallin G 1994 Expression of thyrotoropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic, and neoplastic human thyroid tissue. J Clin Endocrinol Metab 79:384-389.
22. Correa P, Chen VW 1995 Endocrine gland cancer. Cancer 75:338-352.